Home Stock

Stock Research: Krka

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Krka

LJSE:KRKG SI0031102120
94
  • Value
    96
  • Growth
    65
  • Safety
    Safety
    39
  • Combined
    79
  • Sentiment
    99
  • 360° View
    360° View
    94
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Krka dd Novo Mesto is a Slovenia-based pharmaceutical company. It operates in prescription pharmaceuticals, non-prescription products, animal health products, and health resort and tourist services. The company has subsidiaries in Slovenia, Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, and other countries. In the last fiscal year, the company had 12810 employees, a market cap of $7569 million, profits of $1133 million, and revenue of $1977 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 94 (better than 94% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Krka are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Krka. The consolidated Growth Rank has a good rank of 65, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 65% of competitors in the same industry. The consolidated Safety Rank at 96 means that the company has a financing structure that is safer than 96% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 99, which means that professional investors are more optimistic about the stock than for 99% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 39, meaning that the share price of Krka is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 61% of alternative stocks in the same industry. ...read more

more
Country Slovenia
Industry Pharmaceuticals
Size Medium
Website krka.si
Index
Customer Focus EU
Dividends Europe
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 52 83 82
Growth
65 86 35 63
Safety
Safety
96 100 100 100
Sentiment
99 90 92 100
360° View
360° View
94 100 98 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
80 28 87 75
Opinions Change
50 50 6 50
Pro Holdings
n/a 98 76 96
Market Pulse
96 93 95 95
Sentiment
99 90 92 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 52 83 82
Growth
65 86 35 63
Safety Safety
96 100 100 100
Combined
79 100 94 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
26 34 67 66
Price vs. Earnings (P/E)
21 26 48 58
Price vs. Book (P/B)
36 35 57 67
Dividend Yield
88 96 100 100
Value
39 52 83 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
63 52 27 32
Profit Growth
49 59 20 26
Capital Growth
34 74 47 81
Stock Returns
95 94 78 86
Growth
65 86 35 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
90 95 96 91
Refinancing
71 72 81 82
Liquidity
98 100 94 100
Safety Safety
96 100 100 100

Similar Stocks

Discover high‑ranked alternatives to Krka and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Azimut

BIT:AZM
Country: Italy
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.